
Lords Mark Industries Ltd: Revised Financial Results Declared
Lords Mark Industries Ltd has resubmitted its Un-audited Financial Results for the Second Quarter and Half Year Ended September 30, 2026, due to inadvertent typographical errors in the initially submitted Balance Sheet. The revised results, reviewed by the Audit Committee and approved by the Board of Directors on November 14, 2026, incorporate corrections and comply with SEBI (LODR) Regulations, 2015. The company also provided revised key financial factors and management updates on business operations, including significant progress in its medical device division, expansion of manufacturing licenses, and upcoming product launches for sickle cell screening and breast cancer screening devices. Production of AI-based dialysis machines has commenced, and global export shipments are scheduled to begin from December end. The company has also established a US subsidiary, 'Lords Mark Industries Inc.', to manage IVD product exports.
Key Highlights
- Revised Un-audited Financial Results for Q2/H1 FY27 submitted.
- Medical device division shows surge in sales and profitability.
- 26 additional licenses secured for medical device manufacturing.
- AI-based dialysis machine production commenced; global exports to start December.
- US subsidiary established for IVD product exports.
Price Impact
More from LORDSMARK